$130.90
$-0.27 (-0.21%)
End-of-day quote: 05/01/2024
NasdaqGS:SRPT
Sarepta Therapeutics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | NYSE | Outperform | $27.70 | $32.87 | 0.00% | 6 | $153.91B |
| SAN | Sanofi | ENXTPA | Outperform | 91.90€ | 102.80€ | 0.00% | 9 | 116.22€B |
| 4568 | Daiichi Sankyo Company | TSE | Buy | ¥5.50k | ¥5.24k | 0.00% | 0 | ¥10.23T |
| MRNA | Moderna | NasdaqGS | Outperform | $125.59 | $135.42 | 0.00% | 1 | $42.68B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.50T |
| BIIB | Biogen | NasdaqGS | Outperform | $213.51 | $299.62 | 0.00% | 13 | $31.47B |
| BAX | Baxter International Inc | NYSE | Outperform | $36.91 | $44.86 | 0.00% | 5 | $20.55B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $150.31 | $245.24 | 0.00% | 7 | $18.96B |
| BMRN | BioMarin Pharmaceutical | NasdaqGS | Outperform | $83.80 | $111.56 | 0.00% | 5 | $15.82B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $43.09 | $55.60 | 0.00% | 3 | $6.02B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $26.00 | $28.13 | 0.00% | 0 | $2.18B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Outperform | $25.38 | $23.40 | 0.00% | 4 | $2.08B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥4.39k | ¥8.34k | 0.00% | 0 | ¥293.93B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $5.88 | $9.21 | 0.00% | 3 | $602.86M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $11.69 | $19.33 | 0.00% | 3 | $574.86M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.68 | $6.34 | 0.00% | 0 | $491.88M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.65 | $10.21 | 0.00% | 7 | $443.16M |
| PYC | PYC Therapeutics | ASX | Buy | $0.10 | $0.30 | 0.00% | 1 | $294.90M |
| AIM | AIM ImmunoTech | NYSEAM | Buy | $0.39 | $3.83 | 0.00% | 0 | $23.20M |
